Is this you? Create Your Porfile
Avatar

Robert Jean-Jacques

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Robert Jean-Jacques is active.

Explore More

Publication

Featured researches published by Robert Jean-Jacques.

Archive | 2006

Für eine glutamat-dekarboxylase-aktivität kodierende rekombinierende viren

Bemelmans Alexis; Geoffroy Marie-Claude; Horellou Philippe; Julien Jean-Francois; Mallet Jacques; Perricaudet Michel; Robert Jean-Jacques; Vigne Emmanuelle

Archive | 1993

Pharmaceutical compositions and their use, especially for the treatment of neurodegenerative diseases.

Mallet Jacques; Revah Frederic; Robert Jean-Jacques

Archive | 2010

Fremgangsmate for a redusere homologe rekombinasjonsfenomener, defekte rekombinante adenovirus og cellelinje.

Vigne Emmanuelle; Robert Jean-Jacques; Crouzet Joel; Yeh Patrice

Archive | 2010

Menetelmä kaksoissäikeisen nukleiinihapon valmistamiseksi

Mallet Jacques; Revah Frederic; Robert Jean-Jacques

Archive | 2009

VECTORES DE ADENOVIRUS PARA LA TRANSFERENCIA DE GENES EXTRAÑOS EN CELULAS DEL SISTEMA NERVIOSO CENTRAL, PARTICULARMENTE EN EL CEREBRO.

Kahn Axel; Mallet Jacques; Perricaudet Michel; Peschanski Marc; Robert Jean-Jacques

Archive | 2008

DEFICIEN RECOMBINANT ADENOVIRUS VECTORS, METHOD FOR REDUCING HOMOLOGOUS RECOMBINATION PHENOMENA AND METHOD FOR PRODUCING SAID ADENOVIRUSES

Crouzet Joul; Robert Jean-Jacques; Vigne Emmanuelle; Yeh Patrice

Archive | 2008

Method of reducing homologous recombination phenomena, adenoviral vectors and cells containing defective adenovirus

Crouzet Joul; Robert Jean-Jacques; Vigne Emmanuelle; Yeh Patrice

Archive | 2008

ADENOVIRUS VEKTOREN FÜR DIE ÜBERTRAGUNG FREMDER GENE IN ZELLEN DES ZENTRALEN NERVENSYSTEMS, INSBESONDERE IM GEHIRN

Kahn Axel; Mallet Jacques; Perricaudet Michel; Peschanski Marc; Robert Jean-Jacques

Archive | 2006

Anvendelse av en forbindelse som inhiberer bindingen av faktor AP1 til sekvens SEQ ID Nr. 1 til fremstilling av et medikament til behandling av og/eller forebygging av neurodegenerative lidelser.

Mallet Jacques; Robert Jean-Jacques; Revah Frederic

Archive | 2005

UTILIZACION DE COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS.

Mallet Jacques; Revah Frederic; Robert Jean-Jacques

Explore More

Collaboration

Dive into the Robert Jean-Jacques's collaboration.

Top Co-Authors
Avatar

Mallet Jacques

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Vigne Emmanuelle

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Revah Frederic

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Yeh Patrice

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Bemelmans Alexis

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Horellou Philippe

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Julien Jean-Francois

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Geoffroy Marie-Claude

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Perricaudet Michel

French Institute of Health and Medical Research

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge